{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:37:07Z","timestamp":1793752627494,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801458"],"award-info":[{"award-number":["81801458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Youth Innovation in Future Medicine, Chongqing Medical University","award":["W0068"],"award-info":[{"award-number":["W0068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the effect of intrahepatic cholestasis of pregnancy (ICP) with gestational diabetes mellitus (GDM) on perinatal outcomes and establish a prediction model of adverse perinatal outcomes in women with ICP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multicenter retrospective cohort study included the clinical data of 2,178 pregnant women with ICP, including 1,788 women with ICP and 390 co-occurrence ICP and GDM. The data of all subjects were collected from hospital electronic medical records. Univariate and multivariate logistic regression analysis were used to compare the incidence of perinatal outcomes between ICP with GDM group and ICP alone group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Baseline characteristics of the population revealed that maternal age (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), pregestational weight (<jats:italic>p<\/jats:italic>\u2009=\u20090.01), pre-pregnancy BMI (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), gestational weight gain (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), assisted reproductive technology (ART) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and total bile acid concentration (<jats:italic>p<\/jats:italic>\u2009=\u20090.024) may be risk factors for ICP with GDM. Furthermore, ICP with GDM demonstrated a higher association with both polyhydramnios (OR 2.66) and preterm labor (OR 1.67) compared to ICP alone. Further subgroup analysis based on the severity of ICP showed that elevated total bile acid concentrations were closely associated with an increased risk of preterm labour, meconium-stained amniotic fluid, and low birth weight in both ICP alone and ICP with GDM groups. ICP with GDM further worsened these outcomes, especially in women with severe ICP. The nomogram prediction model effectively predicted the occurrence of preterm labour in the ICP population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ICP with GDM may result in more adverse pregnancy outcomes, which are associated with bile acid concentrations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-024-01294-z","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T17:02:34Z","timestamp":1709312554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gestational diabetes mellitus aggravates adverse perinatal outcomes in women with intrahepatic cholestasis of pregnancy"],"prefix":"10.1186","volume":"16","author":[{"given":"Xia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Zhen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Juan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"1294_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/AOG.0000000000000346","volume":"124","author":"C Williamson","year":"2014","unstructured":"Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124:120\u201333.","journal-title":"Obstet Gynecol"},{"key":"1294_CR2","doi-asserted-by":"publisher","first-page":"570e1","DOI":"10.1016\/j.ajog.2015.06.021","volume":"213","author":"T Kawakita","year":"2015","unstructured":"Kawakita T, Parikh LI, Ramsey PS, Huang C-C, Zeymo A, Fernandez M, et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2015;213:570e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1294_CR3","doi-asserted-by":"publisher","first-page":"100e1","DOI":"10.1016\/j.ajog.2014.07.026","volume":"212","author":"L Brouwers","year":"2015","unstructured":"Brouwers L, Koster MPH, Page-Christiaens GCML, Kemperman H, Boon J, Evers IM, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol. 2015;212:100e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"1294_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","volume":"393","author":"C Ovadia","year":"2019","unstructured":"Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet Lond Engl. 2019;393:899\u2013909.","journal-title":"Lancet Lond Engl"},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/hep.20336","volume":"40","author":"A Glantz","year":"2004","unstructured":"Glantz A, Marschall H-U, Mattsson L-A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatol Baltim Md. 2004;40:467\u201374.","journal-title":"Hepatol Baltim Md"},{"key":"1294_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"BE Metzger","year":"2010","unstructured":"International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676\u201382.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"1294_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/dc11-S011","volume":"34","author":"American Diabetes Association","year":"2011","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20132011. Diabetes Care. 2011;34(Suppl 1):11\u201361.","journal-title":"Diabetes Care"},{"key":"1294_CR8","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/ijms19113342","volume":"19","author":"JF Plows","year":"2018","unstructured":"Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes Mellitus. Int J Mol Sci. 2018;19:3342.","journal-title":"Int J Mol Sci"},{"key":"1294_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/1471-0528.12174","volume":"120","author":"E Wikstr\u00f6m Shemer","year":"2013","unstructured":"Wikstr\u00f6m Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG Int J Obstet Gynaecol. 2013;120:717\u201323.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1294_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1515\/jtim-2016-0018","volume":"4","author":"GH Tomkin","year":"2016","unstructured":"Tomkin GH, Owens D. Obesity diabetes and the role of bile acids in metabolism. J Transl Intern Med. 2016;4:73\u201380.","journal-title":"J Transl Intern Med"},{"key":"1294_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1210\/me.2002-0120","volume":"17","author":"I Pineda Torra","year":"2003","unstructured":"Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart J-C, Staels B. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol Baltim Md. 2003;17:259\u201372.","journal-title":"Mol Endocrinol Baltim Md"},{"key":"1294_CR12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1172\/JCI25604","volume":"116","author":"K Ma","year":"2006","unstructured":"Ma K, Saha PK, Chan L, Moore DD. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest. 2006;116:1102\u20139.","journal-title":"J Clin Invest"},{"key":"1294_CR13","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1073\/pnas.0506982103","volume":"103","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A. 2006;103:1006\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1294_CR14","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1080\/07853890.2022.2136400","volume":"54","author":"K Wu","year":"2022","unstructured":"Wu K, Yin B, Li S, Zhu X, Zhu B. Prevalence, risk factors and adverse perinatal outcomes for Chinese women with intrahepatic cholestasis of pregnancy: a large cross-sectional retrospective study. Ann Med. 2022;54:2966\u201374.","journal-title":"Ann Med"},{"key":"1294_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-2008-1078756","volume":"25","author":"RH Lee","year":"2008","unstructured":"Lee RH, Kwok KM, Ingles S, Wilson ML, Mullin P, Incerpi M, et al. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol. 2008;25:341\u20135.","journal-title":"Am J Perinatol"},{"key":"1294_CR16","doi-asserted-by":"crossref","unstructured":"Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Lee RH, Mara Greenberg null, Metz TD, Pettker CM. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011. Am J Obstet Gynecol. 2021;224:B2\u20139.","DOI":"10.1016\/j.ajog.2020.11.002"},{"key":"1294_CR17","doi-asserted-by":"crossref","unstructured":"Sarker M, Zamudio AR, DeBolt C, Ferrara L. Beyond stillbirth: association of intrahepatic cholestasis of pregnancy severity and adverse outcomes. Am J Obstet Gynecol. 2022;227:517.e1-517.e7.","DOI":"10.1016\/j.ajog.2022.06.013"},{"key":"1294_CR18","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/hep.26617","volume":"59","author":"V Geenes","year":"2014","unstructured":"Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatol Baltim Md. 2014;59:1482\u201391.","journal-title":"Hepatol Baltim Md"},{"key":"1294_CR19","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S0140-6736(19)30539-2","volume":"393","author":"Department of Error","year":"2019","unstructured":"Department of Error. Lancet Lond Engl. 2019;393:1100.","journal-title":"Lancet Lond Engl"},{"key":"1294_CR20","doi-asserted-by":"publisher","first-page":"100838","DOI":"10.1016\/j.ajogmf.2022.100838","volume":"5","author":"R Horgan","year":"2022","unstructured":"Horgan R, Bitas C, Abuhamad A. Intrahepatic cholestasis of pregnancy: a comparison of Society for Maternal-Fetal Medicine and the Royal College of Obstetricians and gynaecologists\u2019 guidelines. Am J Obstet Gynecol MFM. 2022;5:100838.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"1294_CR21","doi-asserted-by":"publisher","first-page":"e14574","DOI":"10.1111\/dme.14574","volume":"38","author":"SM Axelsen","year":"2021","unstructured":"Axelsen SM, Kampmann U, Koefoed AS, McIntyre D, Ovesen PG, Fuglsang J. Intrahepatic cholestasis of pregnancy: Association with glycaemic control in gestational diabetes. Diabet Med J Br Diabet Assoc. 2021;38:e14574.","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"1294_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.21037\/atm-20-4879","volume":"8","author":"C Liu","year":"2020","unstructured":"Liu C, Gao J, Liu J, Wang X, He J, Sun J, et al. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes and preeclampsia. Ann Transl Med. 2020;8:1574.","journal-title":"Ann Transl Med"},{"key":"1294_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejogrb.2013.12.037","volume":"176","author":"M Martineau","year":"2014","unstructured":"Martineau M, Raker C, Powrie R, Williamson C. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2014;176:80\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1294_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.5603\/GP.2019.0079","volume":"90","author":"A Majewska","year":"2019","unstructured":"Majewska A, Godek B, Bomba-Opon D, Wielgos M. Association between intrahepatic cholestasis in pregnancy and gestational diabetes mellitus. A retrospective analysis. Ginekol Pol. 2019;90:458\u201363.","journal-title":"Ginekol Pol"},{"key":"1294_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","volume":"5","author":"L Ding","year":"2015","unstructured":"Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 2015;5:135\u201344.","journal-title":"Acta Pharm Sin B"},{"key":"1294_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","volume":"133","author":"SWC Van Mil","year":"2007","unstructured":"Van Mil SWC, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J, et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology. 2007;133:507\u201316.","journal-title":"Gastroenterology"},{"key":"1294_CR27","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/1471-0528.16669","volume":"128","author":"AL Mitchell","year":"2021","unstructured":"Mitchell AL, Ovadia C, Syngelaki A, Souretis K, Martineau M, Girling J, et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study. BJOG Int J Obstet Gynaecol. 2021;128:1635\u201344.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1294_CR28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","volume":"385","author":"L Liu","year":"2015","unstructured":"Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet Lond Engl. 2015;385:430\u201340.","journal-title":"Lancet Lond Engl"},{"key":"1294_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","volume":"371","author":"S Saigal","year":"2008","unstructured":"Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet Lond Engl. 2008;371:261\u20139.","journal-title":"Lancet Lond Engl"},{"key":"1294_CR30","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1016\/S2214-109X(15)00183-7","volume":"3","author":"JP Vogel","year":"2015","unstructured":"Vogel JP, Oladapo OT, Manu A, G\u00fclmezoglu AM, Bahl R. New WHO recommendations to improve the outcomes of preterm birth. Lancet Glob Health. 2015;3:e589\u2013590.","journal-title":"Lancet Glob Health"},{"key":"1294_CR31","doi-asserted-by":"publisher","first-page":"9635526","DOI":"10.1155\/2022\/9635526","volume":"2022","author":"Q Sun","year":"2022","unstructured":"Sun Q, Zou X, Yan Y, Zhang H, Wang S, Gao Y, et al. Machine learning-based prediction model of Preterm Birth using Electronic Health Record. J Healthc Eng. 2022;2022:9635526.","journal-title":"J Healthc Eng"},{"key":"1294_CR32","doi-asserted-by":"publisher","first-page":"100323","DOI":"10.1016\/j.xcrm.2021.100323","volume":"2","author":"AL Tarca","year":"2021","unstructured":"Tarca AL, Pataki B\u00c1, Romero R, Sirota M, Guan Y, Kutum R, et al. Crowdsourcing assessment of maternal blood multi-omics for predicting gestational age and preterm birth. Cell Rep Med. 2021;2:100323.","journal-title":"Cell Rep Med"},{"key":"1294_CR33","doi-asserted-by":"publisher","first-page":"e1003686","DOI":"10.1371\/journal.pmed.1003686","volume":"18","author":"SJ Stock","year":"2021","unstructured":"Stock SJ, Horne M, Bruijn M, White H, Boyd KA, Heggie R, et al. Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): a prospective cohort study and individual participant data meta-analysis. PLoS Med. 2021;18:e1003686.","journal-title":"PLoS Med"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-024-01294-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01294-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T17:13:53Z","timestamp":1709313233000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-024-01294-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1186\/s13098-024-01294-z","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"24 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the ethics committee of Chongqing Medical University, and the content of the approval includes the oral informed consent acquisition scheme and privacy protection method (ID: 2022-011-01). The whole study was carried out in strict accordance with the ethical standards of the institutional research committee and the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There is no conflict of interest among the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"57"}}